EFFICACY OF UPADACITINIB FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE BY DISEASE DURATION: A POST HOC ANALYSIS OF PHASE 3 INDUCTION AND MAINTENANCE STUDIES
Ryan C. Ungaro 1
Jean-Frédéric Colombel 1
Edouard J. Louis 2
Marc Ferrante 3
Takayuki Matsumoto 4
Chirag Doshi 5
Ana Paula Machado De Lacerda 5
Valencia Remple 5
Elena Dubcenco 5
Samuel Anyanwu 5
Andrew Garrison 5
Remo Panaccione 6
1 Icahn School of Medicine at Mount Sinai, New York, United States
2 University Hospital CHU of Liège, Liège, Belgium
3 University Hospitals Leuven, Leuven, Belgium
4 Iwate Medical University, Morioka, Japan
5 AbbVie Inc., North Chicago, United States
6 University of Calgary, Calgary, Canada
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week Copenhagen 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]